YAP1 and malignant colon neoplasm: Elevated YAP expression in colon cancer is clinically associated with poor prognosis, probably through its promotion of immunosuppressive M2 polarization46; thus, targeting intrinsic YAP/TAZ in TAMs could potentially reprogram them toward an antitumoral M1 phenotype, further enhancing immunotherapy efficacy.